The current Standard of Care in COVID is to let people Suffer with Fever,Cough with Supportive Care(paracetamol,cough syrups) till it become Severe enough that Oxygen levels fall and Patient has to be admitted or they spontaneously recover (at which stage steroids can be given)
https://twitter.com/anupampom/status/1317704227381071872
This is not how we practice Medicine.
To let Lung Injury go on unabated will have consequences.
Early treatment is also prevention from Deterioration or long term COVID Symptoms after Recovery.
Unfortunately HCQS has largely failed in early treatment/post exposure trials
To let Lung Injury go on unabated will have consequences.
Early treatment is also prevention from Deterioration or long term COVID Symptoms after Recovery.
Unfortunately HCQS has largely failed in early treatment/post exposure trials
And current lot of oral Antivirals are weak and don't have solid data..
But I sympathize with clinicians who try to throw kitchen sink of weak Antivirals on Pascal's wager (till solid evidence is out)as weak Antivirals are likely to work only early
But I sympathize with clinicians who try to throw kitchen sink of weak Antivirals on Pascal's wager (till solid evidence is out)as weak Antivirals are likely to work only early
I believe More Early outpatient treatment trials should be held in India judging not only progression to ICU as end point,but also including prevention of Household transmission ,Amount of Symptoms developed and Long term COVID Symptoms at end of month as these are all important
• • •
Missing some Tweet in this thread? You can try to
force a refresh
